These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 891477)

  • 41. Endocrine aspects of benign breast disease.
    Parlati E; Liberale I; Travaglini A; Morelli P; Menini E; Dell'Acqua S
    Cancer Detect Prev; 1992; 16(1):25-6. PubMed ID: 1312904
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gynecomastia, prolactin, and other peptide hormones in patients undergoing chronic hemodialysis.
    Nagel TC; Freinkel N; Bell RH; Friesen H; Wilber JF; Metzger BE
    J Clin Endocrinol Metab; 1973 Mar; 36(3):428-32. PubMed ID: 4685384
    [No Abstract]   [Full Text] [Related]  

  • 43. [Gonadotropins and prolactin in gynecomastia; action of dibromoergocryptine (author's transl) (proceedings)].
    Jaffiol C; Robin M; Orsetti A; Mirouze J
    Ann Endocrinol (Paris); 1976; 37(6):469-70. PubMed ID: 799916
    [No Abstract]   [Full Text] [Related]  

  • 44. Serum prolactin levels in patients with fibrocystic breast disease.
    Peters F; Schuth W; Scheurich B; Breckwoldt M
    Obstet Gynecol; 1984 Sep; 64(3):381-5. PubMed ID: 6431348
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Determination of plasma prolactin in patients with breast dysplasia].
    Vázquez Albaladejo C; Ferrer S; Merle S; Sanchis V; Camps Roig J; Giménez Climent J
    Rev Esp Oncol; 1983; 30(3):323-36. PubMed ID: 6571376
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Elevated growth hormone levels in sera from breast cancer patients.
    Emerman JT; Leahy M; Gout PW; Bruchovsky N
    Horm Metab Res; 1985 Aug; 17(8):421-4. PubMed ID: 4054832
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elevated serum prolactin levels after pituitary-stalk section in man.
    Turkington RW; Underwood LE; Van Wyk JJ
    N Engl J Med; 1971 Sep; 285(13):707-10. PubMed ID: 5106280
    [No Abstract]   [Full Text] [Related]  

  • 48. Serum hormones and lipoproteins in benign breast disease.
    Sundaram GS; London R; Margolis S; Wenk R; Lustgarten J; Nair PP; Goldstein P
    Cancer Res; 1981 Sep; 41(9 Pt 2):3814-6. PubMed ID: 6790170
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circulating levels of prolactin in breast cancer patients.
    Mujagić Z; Mujagić H; Prnjavorac B
    Med Arh; 2005; 59(1):33-5. PubMed ID: 15822682
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum prolactin and growth hormone determined by radioimmunoassay and a two-site immunoradiometric assay: comparison with the Nb2 cell bioassay.
    Rose DP; Berke B; Cohen LA
    Horm Metab Res; 1988 Jan; 20(1):49-53. PubMed ID: 3371857
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum prolactin concentration in a prepubertal boy with gynecomastia.
    Johnsonbaugh RE; Horowitz LM; Rogol AD; Karnei RF
    Am J Dis Child; 1978 Apr; 132(4):424. PubMed ID: 645667
    [No Abstract]   [Full Text] [Related]  

  • 52. [Plasma levels of prolactin in women with dysplasia and tumors of the breast (fibroadenoma and carcinoma of the breast)].
    Iturburu Belmonte IM; Basáñez Amuchastegui A; Jiménez Jiménez E; López de Tejada Cabeza I; Goicoechea García J; Méndez Martín J
    Rev Quir Esp; 1988; 15(1):17-21. PubMed ID: 3153353
    [No Abstract]   [Full Text] [Related]  

  • 53. [Radioimmunologic analysis of ferritin, carcinoembryonic antigen and prolactin for evaluating the prognosis and effectiveness of treating breast cancer].
    Skliar SIu; Chebotareva ED; Ganul VL; Korolev VI
    Med Radiol (Mosk); 1987 Oct; 32(10):32-6. PubMed ID: 3657434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prolactin: radioimmunologic levels and changes under ethinyl estradiol and nafoxidine in advanced breast cancers in women].
    Gorins A; Netter A; L'Hermite M
    Ann Endocrinol (Paris); 1973; 34(5):601-2. PubMed ID: 4794619
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Testosterone levels in the plasma of normal women and patients with benign breast disease or with breast cancer.
    Wang DY; Hayward JL; Bulbrook RD
    Eur J Cancer (1965); 1966 Dec; 2(4):373-6. PubMed ID: 5980828
    [No Abstract]   [Full Text] [Related]  

  • 56. Serum prolactin levels before and after galactography in patients with pathological nipple discharge.
    Abet L; Rohde W; Gronke G
    Exp Clin Endocrinol; 1984 Dec; 84(3):360-3. PubMed ID: 6543197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Determining binding proteins of progesterones in patients with breast diseases].
    Kunze M; Voss P; Büttner HH; Strache RR; Röpcke G
    Zentralbl Gynakol; 1989; 111(16):1113-20. PubMed ID: 2816154
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of a low-fat diet on hormone levels in women with cystic breast disease. II. Serum radioimmunoassayable prolactin and growth hormone and bioactive lactogenic hormones.
    Rose DP; Cohen LA; Berke B; Boyar AP
    J Natl Cancer Inst; 1987 Apr; 78(4):627-31. PubMed ID: 3470539
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hormones and the pathophysiology of fibrocystic mastopathy: elevated luteinizing hormone levels.
    Golinger RC; Krebs J; Fisher ER; Danowski TS
    Surgery; 1978 Aug; 84(2):212-5. PubMed ID: 684613
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prolactin serum level in patients with breast cancer.
    Cohen AD; Cohen Y; Maislos M; Buskila D
    Isr Med Assoc J; 2000 Apr; 2(4):287-9. PubMed ID: 10804904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.